deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT02051764

Imaging Characteristics of a Follow-up 18F-AV-1451 Scan

An Open Label, Multicenter Study, Evaluating the Imaging Characteristics of a Follow-up 18F-AV-1451 Scan in Subjects Who Have Had a Prior 18F-AV-1451 Scan

Sponsor: Avid Radiopharmaceuticals

Conditions Alzheimer's Disease
Interventions Brain PET Scan Florbetapir F 18 Flortaucipir F18
Updated 8 times since 2017 Last updated: Sep 3, 2020 Started: May 31, 2014 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lower than expected enrollment

Other terminated trials from Avid Radiopharmaceuticals

See all terminations from Avid Radiopharmaceuticals

Other Alzheimer's Disease trials with similar outcome

Browse all Alzheimer's Disease trials

A PHASE2 clinical study on Alzheimer's Disease, this trial is terminated or withdrawn. The trial is conducted by Avid Radiopharmaceuticals and has accumulated 8 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotEnrolling By Invitation~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Oct 2020 · 28 months · monthly snapshotCompleted~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 12 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  5. Oct 2020 — Jan 2021 [monthly]

    Terminated PHASE2

    Status: Completed → Terminated

▶ Show 3 earlier versions

  1. Jun 2018 — Oct 2020 [monthly]

    Completed PHASE2

  2. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

    Status: Enrolling By Invitation → Completed

  3. Jan 2017 — Feb 2017 [monthly]

    Enrolling By Invitation PHASE2

    First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Avid Radiopharmaceuticals
Data source: Avid Radiopharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations